Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes. - Wikidata - wikimedia - TriplyDB

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

http://www.wikidata.org/entity/Q39956534

about

Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients Nosocomial Outbreak of New Delhi Metallo-β-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study.Efficacy of an Enrichment Media for Increasing Threshold for Carbapenem-Resistant Enterobacteriaceae Screening.Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.In Vitro Activities of Ertapenem and Imipenem against Clinical Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae Collected in Military Teaching Hospital Mohammed V of Rabat.Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study.Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission.Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.Carbapenem-Resistant E. cloacae in Southwest China: Molecular Analysis of Resistance and Risk Factors for Infections Caused by NDM-1-Producers.Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case-control study Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistanc

P2860

Q21134706-B1873B5A-35B8-40B6-889D-7924F4C62F6E Q34320945-2A02BF0C-A9DC-46FD-8660-9B1574553A6D Q34336456-499BE8B8-0EB4-4335-B82B-9C51C5175D63 Q35535751-1EEF6111-363C-4F7C-A0BD-1FE2204459E8 Q35867313-00B63FA4-D73F-44C7-85C3-8E521561C755 Q36757737-D4D24BB6-D004-48FF-A6F8-FFF17A1E1C80 Q40429262-F9DFC10D-28D2-4620-8C8F-C3F550D22D6E Q40871967-F8A51D34-D2E2-4E6B-92BC-667D759AD714 Q41478115-162A1219-83C4-4A1C-8EBC-FC670666F55D Q42141880-AC9F1B1F-EAF2-4BED-B057-837B0D130F52 Q43492512-5687D902-268B-4E6C-B662-676C6160D061 Q44022816-E313ADA8-C8ED-4A17-A590-1F7B59DF7441 Q45223414-7A25E9DD-5DE1-4E9D-944A-8B9B239A410E Q55223840-2197458B-9D60-4C28-868A-8F59AEEF47D0 Q58694373-E6F2C7D4-E429-425C-84CD-16210049E431 Q58694593-246BD63B-C8F9-4D9A-B740-ED8ECB4739A3

P2860

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

http://www.wikidata.org/entity/Q39956534

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@en

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@nl

type

label

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@en

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@nl

prefLabel

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@en

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@nl

P1433

Q39956534-F586C6C8-2916-453C-BE62-82E22A051E7D

P1476

Q39956534-EE153266-1089-496E-AD73-E50C613EF1E6

P2093

Q39956534-6EDC49A9-54CA-4EA3-87C9-72FA09E91003

Q39956534-72CE98A3-5A63-4D6E-8FB5-364E0B3FB562

Q39956534-B203BADF-63D0-4FE7-80E3-F2ECC459D5D1

Q39956534-BC59BFD6-CC1E-483F-9DDE-DEACE2B27D96

Q39956534-C7F628F9-0B74-4EC3-B2FC-F585E50FEDB3

P2860

Q39956534-10634B94-E2CA-4970-A31C-DF0E9E4B3D2E

Q39956534-12D6DEF0-0106-45F2-B969-8AA8909F55AA

Q39956534-142DD896-69C9-4D1B-B22B-DC994E17691D

Q39956534-1CF886C0-02D3-4715-949B-BDB5C808E74E

Q39956534-1E55EE63-D8A2-498C-8349-88AA271ACDFD

Q39956534-1F02BFFA-2A39-4A23-81F4-B78F8E2103CF

Q39956534-34AF275F-B121-4B44-9C85-827B9CC64ECA

Q39956534-35E42A47-83B0-4B43-9203-7645852BF0A5

Q39956534-3A459803-2F14-45AC-8037-37B9A0965CCF

Q39956534-3AF32C08-CA1D-4DA7-9783-22681AD66F87

P304

Q39956534-5A4A1BB0-1A35-42AA-B81C-02CD6865A1C0

P31

Q39956534-A3B14222-FD6D-47DC-AE9F-CC3C44644CD1

P356

Q39956534-CE814D62-3DF6-4CC5-930C-AB10FA85371B

P433

Q39956534-A69A7820-6024-4006-8C6A-7D47649BBA8B

P478

Q39956534-3D492F5F-9733-41FD-A14D-F828F66EA8A6

P577

Q39956534-ECCD75DD-06CE-4575-8737-ACF1066F12F2

P5875

Q39956534-4ECAE67A-2EC1-4C15-A121-2EE63908795B

P698

Q39956534-C871F694-5D61-4E48-A598-D9F4D8AA39F9

P356

P1433

Infection Control and Hospital Epidemiology

P1476

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

@en

P2093

D C Hooper

http://www.w3.org/2001/XMLSchema#string

E P Hyle

http://www.w3.org/2001/XMLSchema#string

H Lee

http://www.w3.org/2001/XMLSchema#string

M J Ferraro

http://www.w3.org/2001/XMLSchema#string

M Silver

http://www.w3.org/2001/XMLSchema#string

P2860

APACHE II: a severity of disease classification system

Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium.

Emerging carbapenemases in Gram-negative aerobes.

Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies.

Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.

Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection.

The current state of multidrug-resistant gram-negative bacilli in North America.

P304

1242-1249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/657138

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47620089

http://www.w3.org/2001/XMLSchema#string

P698

21029005

http://www.w3.org/2001/XMLSchema#string